查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1771021

重症監護診斷市場－全球產業規模、佔有率、趨勢、機會和預測（按測試類型、最終用戶、地區和競爭細分，2020-2030 年）

Critical Care Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Test Type, By End User, By Region & Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 182 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球重症監護診斷市場價值為 13.3 億美元，預計在預測期內將大幅成長，到 2030 年的複合年成長率為 5.11%。由於重症監護環境中對快速精確診斷工具的需求不斷成長，這個市場正在快速發展。隨著全球慢性病的增加和人口老化，敗血症、心臟病、呼吸系統疾病和器官衰竭等急性疾病的盛行率正在迅速上升。這種成長凸顯了能夠早期發現和有效干預的先進診斷技術的必要性。例如，美國 65 歲及以上人口預計將從 2022 年的 5,800 萬增加到 2050 年的 8,200 萬，佔總人口的比例從 17% 成長到 23%，這表明人口結構的急劇變化加劇了對重症監護服務的需求。

市場概覽
預測期 2026-2030
2024年市場規模 13.3億美元
2030年市場規模 17.8億美元
2025-2030 年複合年成長率 5.11%
成長最快的領域 流式細胞儀
最大的市場 北美洲

關鍵市場促進因素

重大疾病發生率上升

主要市場挑戰

高級診斷的費用

主要市場趨勢

分子診斷的進展

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球重症監護診斷市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 按測試類型（流式細胞儀、血液學測試、微生物學和感染性測試、凝血測試、免疫蛋白、常規和特殊化學等）
    • 按最終使用者（手術室、急診室、重症監護室等）
    • 按地區
    • 按公司分類（2024）
  • 市場地圖

第6章：北美重症監護診斷市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲重症監護診斷市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙

第8章：亞太重症監護診斷市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：南美洲重症監護診斷市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章：中東和非洲重症監護診斷市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 近期發展
  • 併購

第 13 章：全球重症監護診斷市場：SWOT 分析

第 14 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代治療類型的威脅

第 15 章：競爭格局

  • Neoplas med GmbH
  • US Medical Innovations
  • Terumo Medical Corp
  • Adtec Plasma Technology Co Ltd
  • Apyx Medical Corp
  • Nordson Corp
  • Europlasma NV
  • Terraplasma GmbH
  • Henniker Plasma
  • Smith & Nephew plc

第 16 章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 16169

The Global Critical Care Diagnostics Market was valued at USD 1.33 billion in 2024 and is projected to grow significantly during the forecast period with a CAGR of 5.11% through 2030F. This market is rapidly evolving, driven by an increasing need for prompt and precise diagnostic tools in critical care environments. With a global rise in chronic diseases and an aging population, the prevalence of acute conditions such as sepsis, cardiac disorders, respiratory diseases, and organ failure is climbing rapidly. This growth underscores the necessity for advanced diagnostics capable of early detection and efficient intervention. For example, the U.S. population aged 65 and older is expected to rise from 58 million in 2022 to 82 million by 2050, growing from 17% to 23% of the total population, illustrating a sharp demographic shift that intensifies demand for critical care services.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 1.33 Billion
Market Size 2030USD 1.78 Billion
CAGR 2025-20305.11%
Fastest Growing SegmentFlow Cytometry
Largest MarketNorth America

Key Market Drivers

Increasing Incidence of Critical Illnesses

A major driver of growth in the critical care diagnostics market is the rising occurrence of severe medical conditions globally. As populations continue to age and lifestyle patterns evolve, conditions such as sepsis, cardiac and respiratory disorders, and organ failure are becoming more widespread. This has amplified the demand for cutting-edge diagnostic technologies that enable swift and accurate identification of these illnesses. Timely diagnosis is essential in critical care as it facilitates early intervention, thereby improving patient recovery and survival rates. According to the World Health Organization (WHO), approximately 422 million individuals were living with diabetes in 2023, predominantly in low- and middle-income countries. With around 1.5 million annual deaths directly attributed to diabetes, the need for early detection and effective management solutions is particularly pressing in resource-limited settings.

Key Market Challenges

Cost of Advanced Diagnostics

One of the foremost challenges in the critical care diagnostics market is the high cost associated with advanced diagnostic technologies. The growing prevalence of life-threatening health conditions, including sepsis, cardiac and respiratory diseases, and organ failure, is fueling the demand for these innovations. However, the financial burden of acquiring and maintaining such sophisticated diagnostic equipment is considerable. This poses a challenge particularly for healthcare providers operating in resource-constrained regions. Additionally, the aging global population adds further pressure on healthcare systems, making cost-effectiveness a crucial factor in the adoption of diagnostic solutions, especially in public and rural healthcare settings.

Key Market Trends

Advancements in Molecular Diagnostics

Technological progress in molecular diagnostics is shaping a key trend in the critical care diagnostics landscape. This approach analyzes genetic material and other molecular indicators to identify diseases, pathogens, or mutations with high precision. The deeper understanding of genetic factors in disease development has allowed for more accurate and personalized diagnostic techniques. Molecular diagnostics enables detection of illnesses at a cellular level, thereby improving diagnostic accuracy and facilitating tailored treatment plans based on individual genetic profiles. This innovation is redefining diagnostic capabilities in critical care by enhancing both speed and specificity of disease identification.

Key Market Players

  • Neoplas med GmbH
  • U.S. Medical Innovations
  • Terumo Medical Corp
  • Adtec Plasma Technology Co Ltd
  • Apyx Medical Corp
  • Nordson Corp
  • Europlasma NV
  • Terraplasma GmbH
  • Henniker Plasma
  • Smith & Nephew plc

Report Scope:

In this report, the Critical Care Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Critical Care Diagnostics Market, Test Type:

  • Flow Cytometry
  • Hematology Test
  • Microbiology and Infectious Test
  • Coagulation Test
  • Immunoprotein
  • Routine and Special Chemistry
  • Others

Critical Care Diagnostics Market, End User:

  • Operating Room
  • Emergency Room
  • Intensive Care Unit
  • Other

Critical Care Diagnostics Market, By Region:

  • North America

United States

Canada

Mexico

  • Europe

Germany

United Kingdom

Italy

France

Spain

  • Asia Pacific

China

India

Japan

South Korea

Australia

  • South America

Brazil

Argentina

Colombia

  • Middle East & Africa

South Africa

Saudi Arabia

UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Critical Care Diagnostics Market.

Available Customizations:

Critical Care Diagnostics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Critical Care Diagnostics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Test Type (Flow Cytometry, Hematology Test, Microbiology and Infectious Test, Coagulation Test, Immunoprotein, Routine, and Special Chemistry, and Others)
    • 5.2.2. By End User (Operating Room, Emergency Room, Intensive Care Unit, and Other)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Critical Care Diagnostics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Test Type
    • 6.2.2. By End User
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Critical Care Diagnostics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Test Type
        • 6.3.1.2.2. By End User
    • 6.3.2. Canada Critical Care Diagnostics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Test Type
        • 6.3.2.2.2. By End User
    • 6.3.3. Mexico Critical Care Diagnostics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Test Type
        • 6.3.3.2.2. By End User

7. Europe Critical Care Diagnostics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Test Type
    • 7.2.2. By End User
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Critical Care Diagnostics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Test Type
        • 7.3.1.2.2. By End User
    • 7.3.2. United Kingdom Critical Care Diagnostics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Test Type
        • 7.3.2.2.2. By End User
    • 7.3.3. Italy Critical Care Diagnostics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecasty
        • 7.3.3.2.1. By Test Type
        • 7.3.3.2.2. By End User
    • 7.3.4. France Critical Care Diagnostics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Test Type
        • 7.3.4.2.2. By End User
    • 7.3.5. Spain Critical Care Diagnostics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Test Type
        • 7.3.5.2.2. By End User

8. Asia-Pacific Critical Care Diagnostics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Test Type
    • 8.2.2. By End User
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Critical Care Diagnostics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Test Type
        • 8.3.1.2.2. By End User
    • 8.3.2. India Critical Care Diagnostics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Test Type
        • 8.3.2.2.2. By End User
    • 8.3.3. Japan Critical Care Diagnostics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Test Type
        • 8.3.3.2.2. By End User
    • 8.3.4. South Korea Critical Care Diagnostics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Test Type
        • 8.3.4.2.2. By End User
    • 8.3.5. Australia Critical Care Diagnostics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Test Type
        • 8.3.5.2.2. By End User

9. South America Critical Care Diagnostics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Test Type
    • 9.2.2. By End User
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Critical Care Diagnostics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Test Type
        • 9.3.1.2.2. By End User
    • 9.3.2. Argentina Critical Care Diagnostics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Test Type
        • 9.3.2.2.2. By End User
    • 9.3.3. Colombia Critical Care Diagnostics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Test Type
        • 9.3.3.2.2. By End User

10. Middle East and Africa Critical Care Diagnostics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Test Type
    • 10.2.2. By End User
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Critical Care Diagnostics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Test Type
        • 10.3.1.2.2. By End User
    • 10.3.2. Saudi Arabia Critical Care Diagnostics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Test Type
        • 10.3.2.2.2. By End User
    • 10.3.3. UAE Critical Care Diagnostics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Test Type
        • 10.3.3.2.2. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions

13. Global Critical Care Diagnostics Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Treatment Types

15. Competitive Landscape

  • 15.1. Neoplas med GmbH
    • 15.1.1. Business Overview
    • 15.1.2. Service Offerings
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. U.S. Medical Innovations
  • 15.3. Terumo Medical Corp
  • 15.4. Adtec Plasma Technology Co Ltd
  • 15.5. Apyx Medical Corp
  • 15.6. Nordson Corp
  • 15.7. Europlasma NV
  • 15.8. Terraplasma GmbH
  • 15.9. Henniker Plasma
  • 15.10. Smith & Nephew plc

16. Strategic Recommendations

17. About Us & Disclaimer